Anna Cristina Garza-Mayers, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitiligo | 2 | 2023 | 89 | 1.400 |
Why?
|
| Calciphylaxis | 5 | 2021 | 124 | 1.230 |
Why?
|
| Cellulitis | 7 | 2022 | 206 | 1.070 |
Why?
|
| Dermatology | 4 | 2023 | 872 | 0.970 |
Why?
|
| Hypopigmentation | 1 | 2023 | 41 | 0.880 |
Why?
|
| Lasers, Dye | 1 | 2022 | 29 | 0.870 |
Why?
|
| Ultraviolet Therapy | 1 | 2023 | 81 | 0.860 |
Why?
|
| Epidermolysis Bullosa Dystrophica | 1 | 2022 | 26 | 0.860 |
Why?
|
| Soft Tissue Injuries | 1 | 2022 | 176 | 0.750 |
Why?
|
| Shigella flexneri | 2 | 2018 | 132 | 0.620 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2016 | 49 | 0.540 |
Why?
|
| Kidney Failure, Chronic | 5 | 2021 | 2538 | 0.520 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2015 | 133 | 0.490 |
Why?
|
| Pyridones | 1 | 2018 | 712 | 0.460 |
Why?
|
| Methotrexate | 2 | 2017 | 1720 | 0.460 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 431 | 0.440 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 498 | 0.400 |
Why?
|
| Virulence Factors | 1 | 2015 | 509 | 0.390 |
Why?
|
| Patch Tests | 2 | 2020 | 53 | 0.380 |
Why?
|
| Students, Medical | 1 | 2023 | 1862 | 0.370 |
Why?
|
| Folic Acid | 1 | 2017 | 1300 | 0.370 |
Why?
|
| Referral and Consultation | 4 | 2022 | 3528 | 0.370 |
Why?
|
| Endocytosis | 1 | 2015 | 985 | 0.370 |
Why?
|
| Skin Diseases | 1 | 2019 | 1065 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 3 | 2018 | 1477 | 0.350 |
Why?
|
| Dermatitis, Allergic Contact | 2 | 2020 | 104 | 0.340 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 1238 | 0.330 |
Why?
|
| Pyrazoles | 1 | 2018 | 1973 | 0.310 |
Why?
|
| Phototherapy | 2 | 2023 | 377 | 0.280 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 2957 | 0.280 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 3849 | 0.260 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4151 | 0.240 |
Why?
|
| Home Care Services | 2 | 2020 | 606 | 0.230 |
Why?
|
| Internship and Residency | 1 | 2023 | 5787 | 0.230 |
Why?
|
| Allergens | 2 | 2020 | 1320 | 0.230 |
Why?
|
| Collagen Type VII | 1 | 2022 | 19 | 0.220 |
Why?
|
| Vascular Diseases | 2 | 2021 | 1161 | 0.210 |
Why?
|
| Blister | 1 | 2022 | 86 | 0.210 |
Why?
|
| Erythema | 1 | 2022 | 257 | 0.190 |
Why?
|
| Thiosulfates | 1 | 2020 | 52 | 0.190 |
Why?
|
| Heart Murmurs | 1 | 2020 | 94 | 0.180 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 5034 | 0.180 |
Why?
|
| Sarcoma, Myeloid | 1 | 2020 | 59 | 0.170 |
Why?
|
| Dysentery, Bacillary | 1 | 2018 | 75 | 0.150 |
Why?
|
| Skin Temperature | 1 | 2017 | 94 | 0.150 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2020 | 336 | 0.140 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 374 | 0.140 |
Why?
|
| Dapsone | 1 | 2016 | 54 | 0.140 |
Why?
|
| Minority Groups | 1 | 2023 | 1223 | 0.140 |
Why?
|
| Retinoids | 1 | 2016 | 101 | 0.130 |
Why?
|
| Vascular Malformations | 1 | 2021 | 454 | 0.130 |
Why?
|
| Phosphatidylinositols | 1 | 2015 | 291 | 0.120 |
Why?
|
| Hydroxychloroquine | 1 | 2016 | 412 | 0.100 |
Why?
|
| Child | 5 | 2023 | 77679 | 0.100 |
Why?
|
| Humans | 26 | 2023 | 744220 | 0.100 |
Why?
|
| Thalidomide | 1 | 2016 | 890 | 0.090 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77426 | 0.090 |
Why?
|
| Laser Therapy | 1 | 2016 | 1072 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2018 | 1787 | 0.080 |
Why?
|
| Skin | 1 | 2022 | 4363 | 0.080 |
Why?
|
| HeLa Cells | 1 | 2015 | 3129 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 1854 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6485 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2018 | 3690 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2018 | 2147 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 7179 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2018 | 3461 | 0.070 |
Why?
|
| Autophagy | 1 | 2013 | 1300 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2013 | 1401 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2018 | 5021 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2023 | 63119 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 3523 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2016 | 2071 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9147 | 0.060 |
Why?
|
| Patient Preference | 2 | 2020 | 887 | 0.060 |
Why?
|
| Bacteria | 1 | 2013 | 2114 | 0.050 |
Why?
|
| Lower Extremity | 2 | 2021 | 1158 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2013 | 2958 | 0.050 |
Why?
|
| Dermatitis, Irritant | 1 | 2020 | 17 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.050 |
Why?
|
| Male | 7 | 2020 | 350027 | 0.050 |
Why?
|
| Female | 7 | 2020 | 380197 | 0.040 |
Why?
|
| Penis | 1 | 2020 | 216 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2020 | 380 | 0.040 |
Why?
|
| Age Factors | 3 | 2020 | 18367 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 213367 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9582 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2018 | 69 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2020 | 981 | 0.040 |
Why?
|
| Body Size | 1 | 2020 | 461 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 40063 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 35129 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 783 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2018 | 249 | 0.040 |
Why?
|
| Hospitals | 2 | 2020 | 3952 | 0.040 |
Why?
|
| Veins | 1 | 2021 | 769 | 0.030 |
Why?
|
| Office Visits | 1 | 2020 | 598 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 40992 | 0.030 |
Why?
|
| Judgment | 1 | 2018 | 281 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 683 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 431 | 0.030 |
Why?
|
| Aged | 4 | 2020 | 163253 | 0.030 |
Why?
|
| Adult | 5 | 2022 | 214035 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 654 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 564 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2018 | 1539 | 0.030 |
Why?
|
| Bacterial Secretion Systems | 1 | 2013 | 38 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1655 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2018 | 648 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1640 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 56436 | 0.030 |
Why?
|
| Warfarin | 1 | 2020 | 1496 | 0.030 |
Why?
|
| Abdomen | 1 | 2018 | 1118 | 0.030 |
Why?
|
| Adolescent | 1 | 2019 | 85759 | 0.020 |
Why?
|
| Risk Factors | 3 | 2022 | 72280 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2018 | 2751 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4929 | 0.020 |
Why?
|
| Caregivers | 1 | 2020 | 2094 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 1053 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9392 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12961 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2018 | 5982 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 6308 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11368 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 3508 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10396 | 0.010 |
Why?
|
| Cell Line | 1 | 2018 | 15999 | 0.010 |
Why?
|
| Macrophages | 1 | 2018 | 5657 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7659 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7730 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13409 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21752 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15070 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13990 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7281 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15538 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 12805 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7723 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53280 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23337 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39045 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40559 | 0.010 |
Why?
|
| Inflammation | 1 | 2013 | 10634 | 0.010 |
Why?
|